Table 2.
Main focus | Minor focus | Concordancerate (%) | Kappa | p-value | ||
---|---|---|---|---|---|---|
Pathological type | IDC | Non-IDC | 78.0 | 0.473 | <0.001 | |
IDC | 236 | 74 | ||||
Non-IDC | 11 | 66 | ||||
Histological grade | I | II | III | 88.4 | 0.772 | <0.001 |
I | 15 | 3 | 0 | |||
II | 3 | 139 | 5 | |||
III | 1 | 16 | 59 | |||
ER | Negative | Positive | 94.3 | 0.841 | <0.001 | |
Negative | 79 | 8 | ||||
Positive | 14 | 286 | ||||
PR | Negative | Positive | 90.7 | 0.798 | <0.001 | |
Negative | 121 | 18 | ||||
Positive | 18 | 230 | ||||
HER2 | Negative | Positive | 93.3 | 0.819 | <0.001 | |
Negative | 279 | 11 | ||||
Positive | 15 | 82 | ||||
Ki67 | < 20% | ≥ 20% | 87.1 | 0.743 | <0.001 | |
< 20% | 163 | 8 | ||||
≥ 20% | 42 | 174 |
ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; PR, progesterone receptor.